Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia, Kidney Disease, Chronic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00526747
What this trial is testing

Erythropoietin Resistance in Anemia of Chronic Kidney Disease

Who this might be right for
AnemiaKidney FailureErythropoietin
Duke University 32
Testing effectiveness (Phase 2)Study completedNCT02021409
What this trial is testing

Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 126
Large-scale testing (Phase 3)Study completedNCT00576303
What this trial is testing

Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.

Who this might be right for
Anemia
Hoffmann-La Roche 200
Large-scale testing (Phase 3)Study completedNCT00077610
What this trial is testing

Intravenous Mircera for the Treatment of Anemia in Dialysis Patients

Who this might be right for
Anemia
Hoffmann-La Roche 673
Large-scale testing (Phase 3)Study completedNCT00442702
What this trial is testing

Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.

Who this might be right for
Anemia
Hoffmann-La Roche 228
Testing effectiveness (Phase 2)Study completedNCT00717366
What this trial is testing

Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis

Who this might be right for
Renal Anemia
Hoffmann-La Roche 64
Not applicableUnknownNCT01785355
What this trial is testing

The Impact Of Periodontal Disease Treatment On The General Health Status In Chronic Haemodialyzed Patients

Who this might be right for
Periodontal DiseaseChronic Kidney Disease
Anemia Working Group Romania 30
Testing effectiveness (Phase 2)Study completedNCT00210743
What this trial is testing

Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.

Who this might be right for
AnemiaKidney Diseases
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 67
Early research (Phase 1)Study completedNCT05636891
What this trial is testing

Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis

Who this might be right for
Chronic Kidney Disease
Nanogen Pharmaceutical Biotechnology Joint Stock Company 43
Large-scale testing (Phase 3)Study completedNCT00925587
What this trial is testing

Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease

Who this might be right for
AnemiaChronic Kidney Disease
Amgen 358
Post-approval studies (Phase 4)Study completedNCT03286712
What this trial is testing

The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients

Who this might be right for
Chronic Kidney DiseaseAnemiaComplication of Peritoneal Dialysis
National Kidney and Transplant Institute, Philippines 30
Large-scale testing (Phase 3)UnknownNCT05211167
What this trial is testing

Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure

Who this might be right for
Kidney Failure, ChronicHemodialysis
Shenyang Sunshine Pharmaceutical Co., LTD. 300
Early research (Phase 1)Study completedNCT04925661
What this trial is testing

HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia

Who this might be right for
Chronic Kidney DiseasesRenal Anemia
Sunshine Lake Pharma Co., Ltd. 40
Post-approval studies (Phase 4)Study completedNCT00369772
What this trial is testing

STAAR-1 Clinical Study

Who this might be right for
Chronic Kidney DiseaseChronic Renal InsufficiencyKidney Disease+2 more
Amgen 2,000
Large-scale testing (Phase 3)Study completedNCT04036253
What this trial is testing

Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease

Who this might be right for
Anemia of Chronic Kidney Disease
Bio Sidus SA 43
Large-scale testing (Phase 3)Ended earlyNCT00454246
What this trial is testing

Mircera in Hemoglobin Control of Patients Transitioning to Dialysis.

Who this might be right for
Anemia
Hoffmann-La Roche 111
Large-scale testing (Phase 3)Study completedNCT00442793
What this trial is testing

A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.

Who this might be right for
Anemia
Hoffmann-La Roche 265
Not applicableUnknownNCT05835648
What this trial is testing

Effect of Dietary Fiber on Non-dialysis Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Qianfoshan Hospital 56
Testing effectiveness (Phase 2)Study completedNCT03519243
What this trial is testing

Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis

Who this might be right for
Anemia
Biocad 75
Large-scale testing (Phase 3)WithdrawnNCT05082584
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents

Who this might be right for
Anemia of Chronic Kidney Disease
Akebia Therapeutics
Next Page